首站-论文投稿智能助手
典型文献
Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements
文献摘要:
BACKGROUND: In the event of a sudden shortage of medical resources, a rapid, simple, and accurate prediction model is essential for the 30-day mortality rate of patients with COVID-19.METHODS: This retrospective study compared the characteristics of the survivals and non-survivals of 278 patients with COVID-19. Logistic regression analysis was performed to obtain the "COVID-19 death risk score" (CDRS) model. Using the area under the receiver operating characteristic (AUROC) curve and Hosmer-Lemeshow goodness-of-fit test, discrimination and calibration were assessed. Internal validation was conducted using a regular bootstrap method. RESULTS: A total of 63 (22.66%) of 278 included patients died. The logistic regression analysis revealed that high-sensitivity C-reactive protein (hsCRP; odds ratio [OR]=1.018), D-dimer (OR=1.101), and respiratory rate (RR; OR=1.185) were independently associated with 30-day mortality. CDRS was calculated as follows: CDRS=?10.245+(0.022×hsCRP)+(0.172×D-dimer)+(0.203×RR). CDRS had the same predictive effect as the sequential organ failure assessment (SOFA) and "confusion, uremia, respiratory rate, blood pressure, and age over 65 years" (CURB-65) scores, with AUROCs of 0.984 for CDRS, 0.975 for SOFA, and 0.971 for CURB-65, respectively. And CDRS showed good calibration. The AUROC through internal validations was 0.980 (95% confidence interval [CI]: 0.965–0.995). Regarding the clinical value, the decision curve analysis of CDRS showed a net value similar to that of CURB-65 in this cohort. CONCLUSION: CDRS is a novel, efficient and accurate prediction model for the early identification of COVID-19 patients with poor outcomes. Although it is not as advanced as the other models, CDRS had a similar performance to that of SOFA and CURB-65.
文献关键词:
作者姓名:
Gui-ying Dong;Fei-fei Jin;Qi Huang;Chun-bo Wu;Ji-hong Zhu;Tian-bing Wang
作者机构:
Emergency Department,Peking University People's Hospital,Beijing 100044,China;Trauma Center,Peking University People's Hospital,Key Laboratory of Trauma and Neural Regeneration(Peking University),Ministry of Education,Beijing100044,China;Department of Endocrinology and Metabolism,Peking University People's Hospital,Beijing100044,China
引用格式:
[1]Gui-ying Dong;Fei-fei Jin;Qi Huang;Chun-bo Wu;Ji-hong Zhu;Tian-bing Wang-.Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements)[J].世界急诊医学杂志(英文),2022(06):453-458
A类:
survivals,245+,uremia,AUROCs
B类:
Exploratory,death,risk,basic,laboratory,tests,physiological,clinical,measurements,BACKGROUND,event,sudden,shortage,medical,resources,rapid,simple,accurate,prediction,essential,day,mortality,patients,METHODS,This,retrospective,study,compared,characteristics,regression,analysis,was,performed,obtain,CDRS,Using,area,under,receiver,operating,curve,Hosmer,Lemeshow,goodness,fit,discrimination,calibration,were,assessed,Internal,conducted,using,regular,bootstrap,method,RESULTS,total,included,died,logistic,revealed,that,high,sensitivity,reactive,protein,hsCRP,odds,dimer,respiratory,RR,independently,associated,calculated,follows,had,same,predictive,effect,sequential,organ,failure,assessment,SOFA,confusion,blood,pressure,over,years,CURB,scores,respectively,And,showed,through,internal,validations,confidence,interval,Regarding,value,decision,net,similar,this,cohort,CONCLUSION,novel,efficient,early,identification,poor,outcomes,Although,not,advanced,other,models,performance
AB值:
0.522855
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Validation of the predictive accuracy of "clinical + morphology nomogram" for the rebleeding risk of ruptured intracranial aneurysms after admission
Sui Jianfei;Wang Nuochuan;Jiang Pengjun;Wu Jun;Wang Qingzhen;Yuan Qiaolin;He Hongwei-Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China;Department of Transfusion, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China;Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China;China National Clinical Research Center for Neurological Diseases, Beijing, People’s Republic of China;Department of Neurointervention, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B:a multi-center retrospective cohort study
Jing Wang;Zequn Lu;Meng Jin;Ying Wang;Kunming Tian;Jun Xiao;Yimin Cai;Yanan Wang;Xu Zhang;Tao Chen;Zhi Yao;Chunguang Yang;Renli Deng;Qiang Zhong;Xiongbo Deng;Xin Chen;Xiang-ping Yang;Gonghong Wei;Zhihua Wang;Jianbo Tian;Xiao-ping Chen-Department of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Epidemiology and Biostatistics,Key Laboratory for Environment and Health,School of Public Health,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Respiratory and Critical Care Medicine,Renmin Hospital of Wuhan University,Wuhan 430060,China;Department of Virology,Wuhan Centers for Disease Prevention and Control,Wuhan 430024,China;Institute of Reproductive Health,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;School of Nursing,Zunyi Medical University,Zunyi 563099,China;Key Laboratory of Environment and Health,Ministry of Education&Ministry of Environmental Protection,and State Key Laboratory of Environmental Health(Incubating),School of Public Health,Tongji Medical College,Huazhong University of Science and Technology Wuhan 430030,China;Department and Institute of Infectious Disease,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Respirology and Tuberculosis Specialty,Wuhan Pulmonary Hospital,Wuhan 430030,China;The Fifth Affiliated(Zhuhai)Hospital of Zunyi Medical University,Zhuhai 519199,China;Department of Critical Care Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Wuhan Jinyintan Hospital,Wuhan 430048,China;Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Immunology,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Biocenter Oulu,Faculty of Biochemistry and Molecular Medicine,University of Oulu,Oulu 90014,Finland;Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。